A Phase III Study Of Postoperative Radiation Therapy (Imrt) +/- Cetuximab For Locally-Advanced Resected Head And Neck Cancer
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Type of Study: Drug
This study will compare the good and bad effects of radiation therapy alone with radiation therapy and cetuximab to find out which is better. Cetuximab is a drug that may delay or prevent tumor growth by blocking certain cellular chemical pathways that lead to tumor development. Follow-up visits wil
Criteria:
Eligible Patients Must Have Head And Neck Cancer That After Surgery Has An Intermediate Risk Of Recu
Keywords:
Head And Neck Cancer, R0920, Recurrent, Resected
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu